Glaxosmithkline reported $18.78B in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 35705M 305M
AstraZeneca AZN:LN 2229663.86M 36335.94M
Aurora Cannabis Inc ACB:CN 236.49M 107.07M
Bristol Myers Squibb BMY:US $ 37107M 343M
Canopy Growth Corp WEED:CN C$ 1.26B 270.14M
Catalent CTLT:US $ 4171M 14M
Corcept Therapeutics CORT:US $ 0M 0M
Eli Lilly And LLY:US $ 14692M 460.9M
GlaxoSmithKline GSK:LN 1878400M 1044200M
Glaxosmithkline GSK:US $ 18784M 10442M
Horizon Pharma HZNP:US $ 2550.99M 1.75M
JAZZ PHA JAZZ:US $ 5990M 2.87M
Lannett LCI:US $ 614.95M 4.87M
Novartis NOVN:VX SF 23784M 589M
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Perrigo Ordinary Shares PRGO:US $ 4086.1M 575.5M
Prestige Brands PBH:US $ 1476.23M 4.93M
Supernus Pharmaceuticals SUPN:US $ 0M 400.38M
Takeda 4502:JP Y 4320357M 178939M
Teva Pharmaceutical TEVA:IT 20.36B 477M
Valeant Pharmaceuticals VRX:CN $ 27885.9M 4717.9M
Zoetis ZTS:US $ 5221M 7M